Alnylam Pharmaceuticals Inc (HAM:DUL)
€ 279.1 +6.6 (+2.42%) Market Cap: 37.70 Bil Enterprise Value: 36.18 Bil PE Ratio: 85.53 PB Ratio: 38.84 GF Score: 74/100
Sorry the transcript is not found. Please try another one.